Quantum computing has moved from theoretical research into a genuine commercial race. IBM has unveiled quantum processors with over 1,000 qubits, while Google has achieved error-corrected quantum computation with logical qubits. Enterprises are beginning to integrate quantum capabilities into hybrid production workflows alongside existing AI infrastructure, and McKinsey projects the quantum comput...
Quantum computing has moved from theoretical research into a genuine commercial race. IBM has unveiled quantum processors with over 1,000 qubits, while Google has achieved error-corrected quantum computation with logical qubits. Enterprises are beginning to integrate quantum capabilities into hybrid production workflows alongside existing AI infrastructure, and McKinsey projects the quantum computing market could reach ... My Top Quantum ETFs For The Next Trend That’s Bigger Than AI QTUM, SOXX,
Douglas Rissing A U.S. judge has refused to reassess a ruling that blocked the Department of Justice from subpoenaing Federal Reserve Chair Jay Powell, marking another setback for prosecutors pursuing a criminal probe tied to the central bank head. Chief U.S. District Judge James Boasberg in Washington, D.C., on Friday denied a request from Jeanine Pirro, U.S. attorney for the District of Columbia...
Douglas Rissing A U.S. judge has refused to reassess a ruling that blocked the Department of Justice from subpoenaing Federal Reserve Chair Jay Powell, marking another setback for prosecutors pursuing a criminal probe tied to the central bank head. Chief U.S. District Judge James Boasberg in Washington, D.C., on Friday denied a request from Jeanine Pirro, U.S. attorney for the District of Columbia, to reconsider his earlier ruling, which had effectively halted the criminal probe into Powell. In his March decision, Boasberg found the subpoenas were improperly motivated, concluding they were aimed at pressuring Powell to comply with demands from Donald Trump to cut interest rates swiftly or step down. Pirro, a close Trump ally, had sought documents related to a $2.5 billion renovation of the Fed’s headquarters, including whether Powell misled Congress about the project. Rejecting the latest motion, Boasberg said prosecutors had "not come close to convincing the court that a different outcome is warranted," adding that prosecutors had a "total lack of a good-faith basis to suspect a crime." The decision marks another legal win for Powell, who has argued the investigation is being used as a tool by Trump to exert political influence over the Federal Reserve and its policy decisions. The ongoing probe has also delayed the confirmation of Kevin Warsh, Trump’s nominee to succeed Powell when his term ends in mid-May. However, Powell has pledged to remain in his role until the investigation is resolved. More on Markets March Jobs Report: A Muddled Picture Strong U.S. Jobs Rebound After Winter Strikes And Storms March Jobs Report: Payroll Strength Offsets Weakness In Participation Global markets pause for Good Friday Catalyst Watch: OPEC meeting, FedEx talks freight, inflation reads, and SpaceX IPO buzz
Veteran justice, 76, was treated for dehydration in March; a retirement would give Trump new chance to shape court US supreme court justice Samuel Alito was reportedly taken to a hospital after becoming sick at a Federalist Society dinner in Philadelphia in March, further fueling speculation that Donald Trump could have more chances to shape the land’s highest court through new appointments. A CNN...
Veteran justice, 76, was treated for dehydration in March; a retirement would give Trump new chance to shape court US supreme court justice Samuel Alito was reportedly taken to a hospital after becoming sick at a Federalist Society dinner in Philadelphia in March, further fueling speculation that Donald Trump could have more chances to shape the land’s highest court through new appointments. A CNN report said Alito was checked by medical staff and given fluids due to dehydration. He later returned to his home in Virginia that same night with his security detail. In the weeks since, Alito has resumed his duties, including participating in oral arguments. Continue reading...
AEON Biopharma (NYSE American: AEON) on Friday said that it had received a notice from NYSE American that it was not in compliance with an additional continued listing standard following its year-end financial results. The company said the latest notice relates to a requirement for stockholders’ equity of at least $4 million, after it reported a deficit of about $55 million as of December 31, 2025...
AEON Biopharma (NYSE American: AEON) on Friday said that it had received a notice from NYSE American that it was not in compliance with an additional continued listing standard following its year-end financial results. The company said the latest notice relates to a requirement for stockholders’ equity of at least $4 million, after it reported a deficit of about $55 million as of December 31, 2025 and losses in three of its four most recent fiscal years. AEON had previously received a notice in February 2025 for failing to meet a separate $2 million equity requirement and was granted until August 3, 2026 to regain compliance. The company said the latest notice does not affect its current listing, and its shares will continue to trade on NYSE American, though they will remain flagged as non-compliant. If AEON fails to regain compliance by the deadline, the exchange may initiate delisting proceedings. AEON +2.61% after hours to $0.912. Source: Press Release More on AEON Biopharma Seeking Alpha’s Quant Rating on AEON Biopharma Historical earnings data for AEON Biopharma Financial information for AEON Biopharma